Dáil Éireann Debate, Wednesday - 17 June 2026
222. Deputy Pádraig O'Sullivan asked the Minister for Health for a full list of all drugs considered by the drugs group in 2025 and 2026, together with the recommendation in respect of each drug; and if she will make a statement on the matter. [46338/26]
View answerUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices.
Information on medicines considered by the HSE Drugs Groups in 2025 and 2026, together with their recommendations, is set out in the HSE Drugs Group minutes, which are publicly available via the Corporate Pharmaceutical Unit at: healthservice.hse.ie/staff/information-healthcare-workers/pcrs/corporate-pharmaceutical-unit/
